Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice
Christian Alan Botz-Zapp, Stephanie L. Foster, Desta M. Pulley, Briana J. Hempel, Guo‐Hua Bi, Zheng‐Xiong Xi, Amy Hauck Newman, David Weinshenker, Daniel F. Manvich
This study examines how the D3R antagonist PG01037 affects morphine-induced behaviors in mice, finding it reduces hyperlocomotion and antinociception but not locomotor sensitization or catalepsy.
Behavioural Brain Research · Aug 2, 2021Peer-reviewedNeuroscience